These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 3953723)
1. Cyclosporine eyedrops for the treatment of severe vernal keratoconjunctivitis. BenEzra D; Pe'er J; Brodsky M; Cohen E Am J Ophthalmol; 1986 Mar; 101(3):278-82. PubMed ID: 3953723 [TBL] [Abstract][Full Text] [Related]
2. Treatment of severe vernal keratoconjunctivitis with cyclosporine A eyedrops. BenEzra D; Matamoros N; Cohen E Transplant Proc; 1988 Apr; 20(2 Suppl 2):644-9. PubMed ID: 3363661 [TBL] [Abstract][Full Text] [Related]
3. Clinical trial with 2% sodium cromoglycate (Opticrom) in vernal keratoconjunctivitis. El Hennawi M Br J Ophthalmol; 1980 Jul; 64(7):483-6. PubMed ID: 6775687 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis. Pucci N; Novembre E; Cianferoni A; Lombardi E; Bernardini R; Caputo R; Campa L; Vierucci A Ann Allergy Asthma Immunol; 2002 Sep; 89(3):298-303. PubMed ID: 12269651 [TBL] [Abstract][Full Text] [Related]
5. Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis. Secchi AG; Tognon MS; Leonardi A Am J Ophthalmol; 1990 Dec; 110(6):641-5. PubMed ID: 2248328 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood. Spadavecchia L; Fanelli P; Tesse R; Brunetti L; Cardinale F; Bellizzi M; Rizzo G; Procoli U; Bellizzi G; Armenio L Pediatr Allergy Immunol; 2006 Nov; 17(7):527-32. PubMed ID: 17014629 [TBL] [Abstract][Full Text] [Related]
7. Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis. Kiliç A; Gürler B Can J Ophthalmol; 2006 Dec; 41(6):693-8. PubMed ID: 17224949 [TBL] [Abstract][Full Text] [Related]
8. [Cyclosporin A 2% eyedrops in therapy of atopic and vernal keratoconjunctivitis]. Tomida I; Schlote T; Bräuning J; Heide PE; Zierhut M Ophthalmologe; 2002 Oct; 99(10):761-7. PubMed ID: 12376851 [TBL] [Abstract][Full Text] [Related]
9. Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: A randomized, comparative, double-blind, crossover study. Pucci N; Caputo R; di Grande L; de Libero C; Mori F; Barni S; di Simone L; Calvani A; Rusconi F; Novembre E Pediatr Allergy Immunol; 2015 May; 26(3):256-261. PubMed ID: 25712437 [TBL] [Abstract][Full Text] [Related]
10. [Prognosis and treatment of Vernal keratoconjunctivitis in pediatric age: pilot study on 197 patients]. Spadavecchia L; Fanelli P; Tesse R; Rizzo G; Procoli U; Bellizzi M; Armenio L Minerva Pediatr; 2010 Jun; 62(3):239-44. PubMed ID: 20467374 [TBL] [Abstract][Full Text] [Related]
11. Montelukast, a leukotriene receptor antagonist, in vernal keratoconjunctivitis associated with asthma. Lambiase A; Bonini S; Rasi G; Coassin M; Bruscolini A; Bonini S Arch Ophthalmol; 2003 May; 121(5):615-20. PubMed ID: 12742837 [TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of Vernal Keratoconjunctivitis and Associated Factors. Nebbioso M; Zicari AM; Celani C; Lollobrigida V; Grenga R; Duse M Semin Ophthalmol; 2015; 30(5-6):340-4. PubMed ID: 24571721 [TBL] [Abstract][Full Text] [Related]
13. An immunohistochemical study of topical cyclosporine in vernal keratoconjunctivitis. el-Asrar AM; Tabbara KF; Geboes K; Missotten L; Desmet V Am J Ophthalmol; 1996 Feb; 121(2):156-61. PubMed ID: 8623884 [TBL] [Abstract][Full Text] [Related]
14. Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis. Doan S; Gabison E; Gatinel D; Duong MH; Abitbol O; Hoang-Xuan T Am J Ophthalmol; 2006 Jan; 141(1):62-66. PubMed ID: 16386977 [TBL] [Abstract][Full Text] [Related]
15. Vernal shield ulcers treated with frequently installed topical cyclosporine 0.05% eyedrops. Westland T; Patryn EK; Nieuwendaal CP; van der Meulen IJE; Mourits MP; Lapid-Gortzak R Int Ophthalmol; 2018 Feb; 38(1):363-368. PubMed ID: 28120172 [TBL] [Abstract][Full Text] [Related]
16. Topical cyclosporine a 1% for the treatment of chronic ocular surface inflammation. Ragam A; Kolomeyer AM; Kim JS; Nayak NV; Fang C; Kim E; Chu DS Eye Contact Lens; 2014 Sep; 40(5):283-8. PubMed ID: 25083780 [TBL] [Abstract][Full Text] [Related]
17. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis. Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889 [TBL] [Abstract][Full Text] [Related]
18. [Cyclosporin A eyedrops for keratitis nummularis after adenovirus keratoconjunctivitis]. Böhringer D; Birnbaum F; Reinhard T Ophthalmologe; 2008 Jun; 105(6):592-4. PubMed ID: 18365204 [TBL] [Abstract][Full Text] [Related]
19. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis. Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058 [TBL] [Abstract][Full Text] [Related]
20. Clinical trial of topical disodium chromoglycate in vernal keratoconjunctivitis. Sayegh F; Samerra'e S; Khateeb M Ophthalmologica; 1978; 177(4):208-13. PubMed ID: 101923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]